Patents by Inventor Christin GALETZKA

Christin GALETZKA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20220168255
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF), More specifically, the present invention relates to a pharmaceutical composition for oral use in treating hyperproliferative, inflammatory or autoimmune disorders by administering a low daily dosage in the range of 410 mg±5% or 400 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: February 16, 2022
    Publication date: June 2, 2022
    Inventors: Christin Galetzka, Chris Rundfeldt, Roland Rupp, Peder M. Andersen
  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20210290582
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF), More specifically, the present invention relates to a pharmaceutical composition for oral use in treating hyperproliferative, inflammatory or autoimmune disorders by administering a low daily dosage in the range of 410 mg±5% or 400 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: October 26, 2020
    Publication date: September 23, 2021
    Inventors: Christin Galetzka, Chris Rundfeldt, Roland Rupp, Peder M. Andersen
  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20190201369
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF), More specifically, the present invention relates to a pharmaceutical composition for oral use in treating hyperproliferative, inflammatory or autoimmune disorders by administering a low daily dosage in the range of 410 mg±5% or 400 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: March 6, 2019
    Publication date: July 4, 2019
    Inventors: Christin GALETZKA, Chris RUNDFELDT, Roland RUPP, Peder M. ANDERSEN
  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20190125711
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF). More specifically, the present invention relates to a pharmaceutical composition for oral use in treating psoriasis by administering a low daily dosage in the range of 375 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: December 20, 2018
    Publication date: May 2, 2019
    Inventors: Christin GALETZKA, Chris RUNDFELDT, Roland RUPP, Peder M. ANDERSEN
  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20180338946
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF), More specifically, the present invention relates to a pharmaceutical composition for oral use in treating hyperproliferative, inflammatory or autoimmune disorders by administering a low daily dosage in the range of 410 mg±5% or 400 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: July 26, 2018
    Publication date: November 29, 2018
    Inventors: Christin GALETZKA, Chris RUNDFELDT, Roland RUPP, Peder M. ANDERSEN
  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20180256530
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF). More specifically, the present invention relates to a pharmaceutical composition for oral use in treating psoriasis by administering a low daily dosage in the range of 375 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: May 15, 2018
    Publication date: September 13, 2018
    Inventors: Christin GALETZKA, Chris RUNDFELDT, Roland RUPP, Peder M. ANDERSEN
  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20180092875
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF), More specifically, the present invention relates to a pharmaceutical composition for oral use in treating hyperproliferative, inflammatory or autoimmune disorders by administering a low daily dosage in the range of 410 mg±5% or 400 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: December 7, 2017
    Publication date: April 5, 2018
    Applicant: FWP IP ApS
    Inventors: Christin GALETZKA, Chris RUNDFELDT, Roland RUPP, Peder M. ANDERSEN
  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20180021289
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF). More specifically, the present invention relates to a pharmaceutical composition for oral use in treating psoriasis by administering a low daily dosage in the range of 375 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: October 3, 2017
    Publication date: January 25, 2018
    Inventors: Christin GALETZKA, Chris RUNDFELDT, Roland RUPP, Peder M. ANDERSEN
  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20170231943
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF), More specifically, the present invention relates to a pharmaceutical composition for oral use in treating hyperproliferative, inflammatory or autoimmune disorders by administering a low daily dosage in the range of 410 mg±5% or 400 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: May 2, 2017
    Publication date: August 17, 2017
    Inventors: Christin GALETZKA, Chris RUNDFELDT, Roland RUPP, Peder M. ANDERSEN
  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20160206586
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF). More specifically, the present invention relates to a pharmaceutical composition for oral use in treating psoriasis by administering a low daily dosage in the range of 375 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: August 26, 2014
    Publication date: July 21, 2016
    Inventors: Christin GALETZKA, Chris RUNDFELDT, Roland RUPP, Peder M. ANDERSEN
  • PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE
    Publication number: 20160206587
    Abstract: The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF), More specifically, the present invention relates to a pharmaceutical composition for oral use in treating hyperproliferative, inflammatory or autoimmune disorders by administering a low daily dosage in the range of 410 mg±5% or 400 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
    Type: Application
    Filed: August 26, 2014
    Publication date: July 21, 2016
    Inventors: Christin GALETZKA, Chris RUNDFELDT, Roland RUPP, Peder M. ANDERSEN